CA-GSD/ANANDA
POSITIVE ALL THE WAY , an award-winning documentary about the Paralympics is now available internationally through Ananda Media. The short documentary, produced by The Foundation for Global Sports Development (GSD) and Sidewinder Films, won “Best Documentary” at the Together! 2020 Disability Film Festival .
With personal interviews and captivating footage, POSITIVE ALL THE WAY celebrates the power of adaptive sport to ignite the human spirit. The film chronicles the growth of the Paralympics under the leadership of Sir Philip Craven, who served as the President of the International Paralympic Committee from 2001 through 2017. Staying true to the integrity of sport and his personal principles, Sir Philip led the sports organization through moments of crisis – such as funding shortfalls and the 2016 Russian doping scandal - while positioning the Paralympics as a leading sports organization.
"Ever since I first met Steven Ungerleider and David Ulich in 2011, I very quickly realized that the true spirit of sport is embodied in everything that The Foundation for Global Sports Development and Sidewinder Films undertakes,” said Sir Philip Craven, who is featured in the film. “In my work with the International Paralympic Committee, I tried to follow that principle and to also follow very closely the vision of the IPC which was ’to enable Para athletes to achieve sporting excellence and inspire and excite the world.’ This is what I believe Sidewinder Films portrays in POSITIVE ALL THE WAY , and I am so pleased that they have partnered with Ananda Media in order that many more people can experience the true spirit of sport!”
"The Paralympic movement reaches across the globe and plays a remarkable role in promoting inclusion worldwide,” said David Ulich, director and producer of the film. “We are delighted to partner with Ananda Media to bring POSITIVE ALL THE WAY to international audiences who can join this movement.”
Dr. Steven Ungerleider, director and producer of POSITIVE ALL THE WAY, agreed. “Sport has the power to change the world, and we are passionate about telling those stories through film. Working with Ananda Media is a perfect fit, and we are honored to have our documentary featured alongside other compelling sports films.”
Ananda Media is a French-based distributor of adventure sports, travel, and healthy lifestyle content. Much of their content, including POSITIVE ALL THE WAY , is available on-demand for worldwide audiences. Visit http://anandamedia.net to learn more.
About Ananda Media
Ananda Media is a producer and distributor of action sports and adventure travel programming for television and digital media. We pride ourselves on working with the top independent film-makers, and TV Channels in order to ensure that our content offering is both unparalleled and broadcast, streamed or downloaded to millions around the world.
More info: http://anandamedia.net
About The Foundation for Global Sports Development and Sidewinder Films
The Foundation for Global Sports Development, established in 1996, was born out of a desire to promote and protect the best parts of sport. Guided by its original mission, the foundation delivers and supports initiatives that promote accessible, fair, and abuse-free sport for youth. The foundation achieves this objective through grants, awards, educational projects, and filmmaking. In 2015, the foundation launched its media company, Sidewinder Films, to inspire and educate audiences through films that shed light on the remarkable, untold stories that celebrate the sport of life. Visit www.globalsportsdevelopment.org and www.sidewinderfilms.org to learn more.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210323005297/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SIAL Paris 2026 : The Entire Food Industry in One Place – An Unmissable Event for Professionals8.12.2025 09:00:00 CET | Press release
SIAL Paris 2026 is more than ever the world’s must-attend food industry event With less than a year to go, SIAL Parisonce again stands as a key international gathering for food industry professionals. With 85% of exhibition space already booked, the show demonstrates very strong momentum and appeal. SIAL Paris will welcome 295,000 professionals from 200 countries across a stunning 280,000 m² of exhibition space, covering all sectors of the food industry. Innovation at the core of global food transformation In a context marked by major demographic, environmental and geopolitical challenges, SIAL Paris stands as THE hub where innovation drives action, business, and transformation. It brings across all sectors’ ideas, projects, and solutions that address today’s challenges, all while inspiring food business around the world. As in every edition, the show will offer a unique immersive experience, facilitating meaningful meetings and business opportunities. SIAL Paris serves as the global i
Merz Therapeutics to Present Broad Range of Clinical, Real-World and Mechanistic Data at TOXINS 20268.12.2025 08:00:00 CET | Press release
Merz Therapeutics to present more than 20 abstracts and posters at the TOXINS 2026 8th International Conference, taking place January 14-17 2026 in Madrid, Spain. Merz Therapeutics, a leading player in neurology-focused specialty pharma, today announced that the company will present more than 20 clinical and non-clinical abstracts and posters spanning spasticity, movement disorders, and neurotoxin science at the TOXINS 2026 8th International Conference, taking place January 14–17, 2026, in Madrid, Spain. These presentations underscore the company’s commitment to addressing unmet needs in neurological disorders. “Our research reflects a relentless focus on improving patient outcomes through innovation in neurotoxin science,” said Dr. Stefan Albrecht, Chief Scientific and Medical Officer at Merz Therapeutics. “By presenting these new data at TOXINS 2026, we aim to foster scientific exchange and advance treatment strategies that address real-world challenges for patients and clinicians.”
Galderma Welcomes Increased Equity Investment From L’Oréal8.12.2025 07:05:00 CET | Press release
L’Oréal to acquire an additional 10% stake in Galderma recognizing its scientific leadership in dermatology and long-term growth potential Ad hoc announcement pursuant to Art. 53 LR Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that L’Oréal Groupe intends to increase its equity investment in the company, acquiring an additional 10% stake from Sunshine SwissCo GmbH (a consortium led by EQT, Abu Dhabi Investment Authority (ADIA), and Auba Investment Pte. Ltd., acting as sellers). Following the transaction, which is subject to customary approvals, L’Oréal’s total shareholding in Galderma will rise to 20%, building on its initial investment made in August 2024. The transaction is expected to close in Q1 2026. In connection with this increased investment, Galderma will consider nominating two non-independent board candidates from L’Oréal, replacing the board members representing the consortium led by EQT, at the 2026 Annual General Meeting. Additio
Ant International Wins Champion of NeurIPS Competition of Fairness in AI Face Detection8.12.2025 04:37:00 CET | Press release
The Challenge: Deepfakes undermine both the accuracy and fairness of AI face detection due to variations in human features.The Technology: Ant International’s AI model uses a novel ‘Mixture of Experts’-based Adversarial Debiasing approach to achieve superior fairness and accuracy across diverse demographics.The Impact: This advancement strengthens payment security, offering robust protection against deepfake fraud and enhancing eKYC compliance globally. Ant International, a leading global digital payment, digitisation, and financial technology provider, has won first place at the NeurIPS Competition of Fairness in AI Face Detection. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207210856/en/ Ant International’s solution takes top spot at the NeurIPS Competition of Fairness in AI Face Detection, emerging first among over 2,100 submissions from 162 teams globally. AI Fairness enhances Financial Security Studies by the Nati
Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies8.12.2025 00:00:00 CET | Press release
Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLLSonrotoclax in combination with BRUKINSA demonstrated rapid MRD negativity in treatment-naive CLL, regardless of high-risk features BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating meaningful clinical benefit as monotherapy and in combination across B-cell malignancies. These data were featured at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Florida. The five presentations highlight durable responses in heavily pretreated patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) and additional studies showing deep, rapid, and sustained undetectable minimal residual disease (uMRD) rates with sonrotoclax-based combinations in patients with treatment-naive chronic lymphocytic leukemi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom